enVVeno Medical (id:5860 NVNO)
3.41 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 3:13:38 PM)
Exchange closed, opens in 18 hours 16 minutes
About enVVeno Medical
Market Capitalization 59.80M
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of venous Chronic Venous Insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg; and enVVe, a non-surgical, transcatheter based replacement venous valve for the treatment of CVI. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
| Headquarters (address) |
70 Doppler Irvine 92618 CA United States |
| Phone | 949 261 2900 |
| Website | https://www.envveno.com |
| Employees | 31 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Ticker | NVNO |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 3.01 - 6.97 |
| Market Capitalization | 59.80M |
| P/E trailing | -1.79 |
| P/E forward | -2.87 |
| Price/Book | 1.26 |
| Beta | 1.22 |
| EPS | -1.29 |
| EPS United States (ID:6, base:3402) | 24.22 |